The week of Oct. 20 is scheduled for four IPOs to begin trading in the public markets. All four companies will list on the Nasdaq, set for about $300 million to be raised.
Full IPO calendar HERE In order of largest IPO first.
(1) Based in Greenwich, CT, Fifth Street Asset Management (FSAM) scheduled a $200 million on the Nasdaq with a market capitalization of $1.2 billion at a price range midpoint of $25 for Wednesday, Oct. 22, 2014.
FSAM is a leading alternative asset manager with more than $5.6 billion of assets under management.
(2) Based in Waltham, MA, Proteon Therapeutics (PRTO) scheduled a $61 million IPO on Nasdaq with a market capitalization of $183 million at a price range midpoint of $13 for Wednesday, Oct. 22, 2014.
Targeting kidney failure, PRTO initiated the first of two Phase 3 trials for PRT-201 in radiocephalic AVFs, PRTO’s initial indication, in the third quarter of 2014 and expect to initiate the second Phase 3 trial in the first half of 2015.
(3) Based in St. Louis, MO, EndoStim (STIM) scheduled a $35 million IPO on the Nasdaq with a market capitalization of $92 million at a price range midpoint of $11 for the week of October 20, 2014.
STIM is a medical device company focused on the development and commercialization of a novel neurostimulation system for the treatment of severe gastroesophageal reflux disease, or GERD.
(4) Based in Madison, WI, Anchor BanCorp Wisconsin (ABCW) scheduled a $10 million IPO on the Nasdaq with a market capitalization of $242 million at a price range midpoint of $26 for the week of October 20, 2014.
ABCW is a bank incorporated as a savings and loan holding company under the laws of the State of Delaware and headquartered in Madison, Wisconsin.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer